7-128841304-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 18P and 4B. PVS1PM2PP5_Very_StrongBS2
The NM_001458.5(FLNC):c.1948C>T(p.Arg650Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001458.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNC | NM_001458.5 | c.1948C>T | p.Arg650Ter | stop_gained | 12/48 | ENST00000325888.13 | NP_001449.3 | |
FLNC | NM_001127487.2 | c.1948C>T | p.Arg650Ter | stop_gained | 12/47 | NP_001120959.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLNC | ENST00000325888.13 | c.1948C>T | p.Arg650Ter | stop_gained | 12/48 | 1 | NM_001458.5 | ENSP00000327145 | P3 | |
FLNC | ENST00000346177.6 | c.1948C>T | p.Arg650Ter | stop_gained | 12/47 | 1 | ENSP00000344002 | A1 | ||
FLNC | ENST00000388853.3 | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461798Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727186
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:5
Likely pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 15, 2023 | Has been reported in association with DCM in published literature (Morales et al., 2020) and in an individual tested at GeneDx; Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26899768, 15929027, 32112656, 32160020, 36472615) - |
Pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The p.R650* pathogenic mutation (also known as c.1948C>T), located in coding exon 12 of the FLNC gene, results from a C to T substitution at nucleotide position 1948. This changes the amino acid from an arginine to a stop codon within coding exon 12. This alteration has been reported in dilated cardiomyopathy (DCM) cohorts (Bourfiss M et al. Circ Genom Precis Med, 2022 Dec;15:e003704; Lian H et al. J Transl Med, 2023 Jul;21:476). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation for FLNC-related DCM; however, its clinical significance for FLNC-related hypertrophy/restrictive cardiomyopathy and/or skeletal myopathy is uncertain. - |
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 28, 2023 | This sequence change creates a premature translational stop signal (p.Arg650*) in the FLNC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLNC are known to be pathogenic (PMID: 27908349). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FLNC-related conditions. ClinVar contains an entry for this variant (Variation ID: 421215). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at